Literature DB >> 2840656

Crystallization of purified recombinant human interleukin-1 beta.

D B Carter1, K A Curry, C S Tomich, A W Yem, M R Deibel, D E Tracey, J W Paslay, J B Carter, N Y Theriault, P K Harris.   

Abstract

The gene for human interleukin-1 beta was cloned from SK-hep-1 hepatoma cellular RNA and expressed at high levels in Escherichia coli both as the naturally processed form (rIL-1 beta) and as a variant with an additional sequence of three amino acids on the N-terminus (rIL-1 beta +). Expressed protein was purified to homogeneity by a sequence of steps, which included low pH incubation, adsorption and desorption from Procion Red Sepharose, sizing on a Superose 12 fast-performance liquid chromatography (FPLC) column, and anion exchange chromatography on QAE Sepharose. The final step provided a biologically active protein that migrates on two-dimensional (2-D) gels as a single spot with a pI of 6.7 +/- 0.2 and a molecular mass of 17,500 daltons. Concentrated solutions of rIL-1 beta have produced crystals by ammonium sulfate precipitation. The crystals are tetragonal, show the symmetry of space group P4(1) or its enantiomer, have lattice constants of a = 58.46 (1) and c = 77.02 (3) A, and scatter to at least 2 A resolution. A structure determination based on these crystals is under way.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840656     DOI: 10.1002/prot.340030207

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  3 in total

1.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

2.  Chemical modification of interleukin-1 beta: biochemical characterization of a carbodiimide-catalyzed intramolecular cross-linked protein.

Authors:  A W Yem; D M Guido; W R Mathews; N D Staite; K A Richard; M D Prairie; W C Krueger; D E Epps; M R Deibel
Journal:  J Protein Chem       Date:  1992-12

3.  Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.

Authors:  E Labriola-Tompkins; C Chandran; K L Kaffka; D Biondi; B J Graves; M Hatada; V S Madison; J Karas; P L Kilian; G Ju
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.